|
MY125870A
(en)
*
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system flow modulator apparatus and method
|
|
JP4173635B2
(en)
|
1997-12-29 |
2008-10-29 |
インターシア セラピューティクス，インコーポレイティド |
Permeation supply apparatus having membrane plug holding mechanism
|
|
US7258869B1
(en)
*
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
|
WO2002036072A2
(en)
*
|
2000-11-03 |
2002-05-10 |
Biomedicines, Inc. |
Method for short-term and long-term drug dosimetry
|
|
US6756049B2
(en)
|
2000-12-29 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
|
WO2002053128A2
(en)
*
|
2001-01-03 |
2002-07-11 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
|
CA2433032C
(en)
*
|
2001-01-03 |
2008-11-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with coated drug cores
|
|
US7163688B2
(en)
*
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
|
CA2460334A1
(en)
|
2001-09-14 |
2003-03-27 |
Francis J. Martin |
Microfabricated nanopore device for sustained release of therapeutic agent
|
|
EP1536839B1
(en)
*
|
2001-11-09 |
2010-09-15 |
Intarcia Therapeutics, Inc |
Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus
|
|
CA2489325C
(en)
*
|
2002-06-17 |
2010-08-10 |
Alza Corporation |
Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
|
|
US20040059228A1
(en)
*
|
2002-09-23 |
2004-03-25 |
Scimed Life Systems, Inc. |
Systems and methods for flushing catheters
|
|
CA2502378A1
(en)
*
|
2002-10-29 |
2004-05-13 |
Alza Corporation |
Stabilized, solid-state polypeptide particles
|
|
EP1578398A2
(en)
*
|
2002-12-19 |
2005-09-28 |
ALZA Corporation |
Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
|
|
US7731947B2
(en)
*
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
CA2520775A1
(en)
*
|
2003-03-31 |
2004-10-21 |
Alza Corporation |
Non-aqueous single phase vehicles and formulations utilizing such vehicles
|
|
NZ542779A
(en)
*
|
2003-03-31 |
2009-02-28 |
Intarcia Therapeutics Inc |
Osmotic pump with means for dissipating internal pressure by allowing osmotic material to be ejected from the container above a set internal pressure
|
|
TW200509999A
(en)
*
|
2003-03-31 |
2005-03-16 |
Alza Corp |
Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
|
|
US20040265351A1
(en)
*
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
|
CA2523859C
(en)
|
2003-04-29 |
2011-08-02 |
The General Hospital Corporation |
Methods and devices for the sustained release of multiple drugs
|
|
US20090208540A1
(en)
*
|
2003-08-11 |
2009-08-20 |
Indevus Pharmaceuticals, Inc. |
Implantable device for the delivery of naltrexone and methods of use thereof
|
|
CA2437639C
(en)
|
2003-08-11 |
2016-07-05 |
Valera Pharmaceuticals, Inc. |
Long term drug delivery devices with polyurethane based polymers and their manufacture
|
|
US7858110B2
(en)
|
2003-08-11 |
2010-12-28 |
Endo Pharmaceuticals Solutions, Inc. |
Long term drug delivery devices with polyurethane based polymers and their manufacture
|
|
CA2538043A1
(en)
|
2003-09-30 |
2005-04-14 |
Alza Corporation |
Osmotically driven active agent delivery device providing an ascending release profile
|
|
WO2005044239A2
(en)
|
2003-10-31 |
2005-05-19 |
Alza Corporation |
Osmotic pump with self-retaining, fast-start membrane plug
|
|
EP1694310A2
(en)
*
|
2003-11-06 |
2006-08-30 |
Alza Corporation |
Modular imbibition rate reducer for use with implantable osmotic pump
|
|
US20050175701A1
(en)
*
|
2004-02-10 |
2005-08-11 |
Alza Corporation |
Capillary moderator for osmotic delivery system
|
|
US20050266087A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
|
US7117870B2
(en)
*
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
|
US20060045891A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Lovalenti Phillip M |
Density-matched suspension vehicles and pharmaceutical suspensions
|
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
US20060216242A1
(en)
*
|
2005-02-03 |
2006-09-28 |
Rohloff Catherine M |
Suspending vehicles and pharmaceutical suspensions for drug dosage forms
|
|
JP2008528698A
(en)
*
|
2005-02-03 |
2008-07-31 |
インターシア セラピューティクス，インコーポレイティド |
Implantable interferon-containing devices
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US7959938B2
(en)
*
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
|
US20070015689A1
(en)
|
2005-06-23 |
2007-01-18 |
Alza Corporation |
Complexation of metal ions with polypeptides
|
|
US20070027105A1
(en)
*
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US7790671B2
(en)
*
|
2005-10-07 |
2010-09-07 |
Codman & Shurtleff, Inc. |
Implantable pump for protein delivery for obesity control by drug infusion into the brain
|
|
DK2020990T3
(en)
|
2006-05-30 |
2010-12-13 |
Intarcia Therapeutics Inc |
An internal channel flow modulator for a two-part osmotic feeding system
|
|
KR101200728B1
(en)
*
|
2006-08-09 |
2012-11-13 |
인타르시아 세라퓨틱스 인코포레이티드 |
Osmotic delivery system and piston assemblies
|
|
ES2402172T3
(en)
*
|
2007-04-23 |
2013-04-29 |
Intarcia Therapeutics, Inc |
Suspension formulation of insulinotropic peptides and uses thereof
|
|
FI7960U1
(en)
*
|
2007-04-27 |
2008-07-28 |
Bayer Schering Pharma Oy |
Membrane shell for an implantable dosing system
|
|
DK2240155T3
(en)
*
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Devices, formulations and methods for the delivery of several beneficial agents
|
|
US20110236456A1
(en)
*
|
2008-09-30 |
2011-09-29 |
Endo Pharmaceuticals Solutions Inc. |
Implantable device for the delivery of histrelin and methods of use thereof
|
|
RU2510266C2
(en)
*
|
2008-09-30 |
2014-03-27 |
Эндо Фармасьютикалз Солюшнз Инк. |
Implanted risperidone delivery system and methods for using it
|
|
EP2349200A1
(en)
*
|
2008-10-15 |
2011-08-03 |
Intarcia Therapeutics, Inc |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
|
RU2753280C2
(en)
|
2009-09-28 |
2021-08-12 |
Интарсия Терапьютикс, Инк. |
Rapid accomplishment and/or termination of substantial stable drug delivery
|
|
AU2010313456A1
(en)
|
2009-10-30 |
2012-05-17 |
Ntf Therapeutics, Inc. |
Improved neurturin molecules
|
|
US8038650B2
(en)
*
|
2010-02-22 |
2011-10-18 |
Microsert Ltd. |
Slow release liquid drug delivery device
|
|
CN103118692A
(en)
|
2010-04-26 |
2013-05-22 |
Atyr医药公司 |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
|
|
CA2797362C
(en)
|
2010-04-27 |
2020-12-08 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
|
|
US8993723B2
(en)
|
2010-04-28 |
2015-03-31 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
|
|
CN103097523B
(en)
|
2010-04-29 |
2016-09-28 |
Atyr医药公司 |
The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Asparaginyl-tRNA synthetase finds
|
|
WO2011139907A2
(en)
|
2010-04-29 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
|
|
CN103140233B
(en)
|
2010-05-03 |
2017-04-05 |
Atyr 医药公司 |
Treatment, diagnosis and the discovery of antibody compositions related to the protein fragments of methionyl-tRNA synthetase
|
|
CA2797977C
(en)
|
2010-05-03 |
2019-08-20 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
|
|
US8961961B2
(en)
|
2010-05-03 |
2015-02-24 |
a Tyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases
|
|
EP2566499B1
(en)
|
2010-05-04 |
2017-01-25 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
|
|
CN103200953B
(en)
|
2010-05-14 |
2017-02-15 |
Atyr 医药公司 |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
|
|
CN103096914B
(en)
|
2010-05-17 |
2015-08-12 |
Atyr医药公司 |
The innovation of the treatment relevant to the protein fragments of Leucyl-tRNA synthetase, diagnosis and antibody compositions finds
|
|
JP6046607B2
(en)
|
2010-05-27 |
2016-12-21 |
エータイアー ファーマ， インコーポレイテッド |
Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glutaminyl tRNA synthetase
|
|
WO2011153277A2
(en)
|
2010-06-01 |
2011-12-08 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
|
|
EP2593125B1
(en)
|
2010-07-12 |
2017-11-01 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
|
|
US9029506B2
(en)
|
2010-08-25 |
2015-05-12 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-tRNA synthetases
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
CA2838326C
(en)
*
|
2011-06-15 |
2018-05-01 |
Orient Pharma Co., Ltd. |
Multi-layer capsule and manufacture method thereof
|
|
WO2013188199A1
(en)
*
|
2012-06-14 |
2013-12-19 |
Ceramatec, Inc. |
Apparatus and method for delivering beneficial liquids at a consistent rate
|
|
CA3177929A1
(en)
|
2012-12-21 |
2014-06-26 |
Astellas Institute For Regenerative Medicine |
Methods for production of platelets from pluripotent stem cells and compositions thereof
|
|
JP6564369B2
(en)
|
2013-12-09 |
2019-08-21 |
デュレクト コーポレイション |
Pharmaceutically active agent conjugates, polymer conjugates, and compositions and methods involving them
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
KR102650751B1
(en)
|
2015-06-03 |
2024-03-22 |
인타르시아 세라퓨틱스 인코포레이티드 |
Implant placement and removal systems
|
|
CA3003747A1
(en)
|
2015-11-05 |
2017-05-11 |
The General Hospital Corporation |
Intrathecal delivery of nucleic acid sequences encoding abcd1 for treatment of adrenomyeloneuropathy
|
|
TWI814219B
(en)
|
2016-05-16 |
2023-09-01 |
美商因塔希亞治療公司 |
Glucagon-receptor selective polypeptides and methods of use thereof
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
KR20190086460A
(en)
|
2016-10-20 |
2019-07-22 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
Methods for delivering neuroprotective polypeptides to the central nervous system
|
|
US10835580B2
(en)
|
2017-01-03 |
2020-11-17 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
|
AU2018231249A1
(en)
|
2017-03-08 |
2019-09-26 |
Intarcia Therapeutics, Inc |
Apparatus and methods for administration of a nauseogenic compound from a drug delivery device
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
CN113195524A
(en)
|
2018-10-11 |
2021-07-30 |
因塔西亚治疗公司 |
Human amylin analog polypeptides and methods of use
|
|
JP2023515918A
(en)
|
2020-01-13 |
2023-04-17 |
デュレクト コーポレーション |
Sustained release drug delivery system with reduced impurities and related methods
|